What makes OTLK special is how much we can predict.
- Norse 8 very likely to succeed - OTLK will get a meaningful share of the US and EU market. Laws in both regions compel this and legal liability and the need for health care cost control will drive this outcome. - Any reasonable assumption on price per inject ($200 - $500) yields significant revenue. - Any reasonable revenue multiple yields a much higher stock ($40 - $400)
The risk is financing, which can be solved by those holding a significant share of the equity.
By the way, my price prediction included FDA approval and sales in US! Also your math and overall comprehension is terrible, but ok go ahead and sell at $10 then buddy
Market Data 
Markets 
AI
